DE2119451A1 - Gegen dje Mareksche Krankheit nützliche Sulfanilylphenylharnstoff-Komplexe - Google Patents

Gegen dje Mareksche Krankheit nützliche Sulfanilylphenylharnstoff-Komplexe

Info

Publication number
DE2119451A1
DE2119451A1 DE19712119451 DE2119451A DE2119451A1 DE 2119451 A1 DE2119451 A1 DE 2119451A1 DE 19712119451 DE19712119451 DE 19712119451 DE 2119451 A DE2119451 A DE 2119451A DE 2119451 A1 DE2119451 A1 DE 2119451A1
Authority
DE
Germany
Prior art keywords
integer
organic compound
hydrogen
carbon atoms
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19712119451
Other languages
German (de)
English (en)
Inventor
William Vance Scotch Plains N.J. Ruyle (V .StA.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE2119451A1 publication Critical patent/DE2119451A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19712119451 1970-04-22 1971-04-21 Gegen dje Mareksche Krankheit nützliche Sulfanilylphenylharnstoff-Komplexe Pending DE2119451A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3102570A 1970-04-22 1970-04-22

Publications (1)

Publication Number Publication Date
DE2119451A1 true DE2119451A1 (de) 1971-11-11

Family

ID=21857254

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19712119451 Pending DE2119451A1 (de) 1970-04-22 1971-04-21 Gegen dje Mareksche Krankheit nützliche Sulfanilylphenylharnstoff-Komplexe

Country Status (9)

Country Link
US (1) US3717623A (OSRAM)
BE (1) BE766072A (OSRAM)
CA (1) CA951726A (OSRAM)
CH (1) CH554874A (OSRAM)
DE (1) DE2119451A1 (OSRAM)
FR (1) FR2092072B1 (OSRAM)
GB (1) GB1311618A (OSRAM)
NL (1) NL7104785A (OSRAM)
ZA (1) ZA712566B (OSRAM)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3960955A (en) * 1974-11-15 1976-06-01 Texaco Inc. Purification process
US3998853A (en) * 1975-12-04 1976-12-21 Phillips Petroleum Company 13-Oxatetracyclo[8.2.12,9.0.03,8 ]tridec-5-ene-1,5,6,10-tetracarbonitrile
US4338334A (en) * 1977-12-29 1982-07-06 Merck & Co., Inc. 1-[4-(4-Sulfanilyl)phenyl] urea and derivatives in compositions and methods of treating rheumatoid arthritis and immune complex diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2328548A (en) * 1939-05-27 1943-09-07 Schering Corp Therapeutically valuable derivative of sulfones
GB987252A (en) * 1960-08-29 1965-03-24 Monsanto Canada Ltd Bacteriostatic adducts of pyridine and pyrimidine derivatives

Also Published As

Publication number Publication date
GB1311618A (en) 1973-03-28
FR2092072A1 (OSRAM) 1972-01-21
BE766072A (fr) 1971-10-21
NL7104785A (OSRAM) 1971-10-26
ZA712566B (en) 1972-12-27
CA951726A (en) 1974-07-23
CH554874A (de) 1974-10-15
US3717623A (en) 1973-02-20
FR2092072B1 (OSRAM) 1974-05-24

Similar Documents

Publication Publication Date Title
DE1468337A1 (de) Verfahren zur Herstellung von Carbanilidverbindungen
DE1795833A1 (de) Fungicide zusammensetzungen und verfahren zur herstellung derselben
DE2830007C3 (de) Inosadiaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Antitumormittel
DE2119451A1 (de) Gegen dje Mareksche Krankheit nützliche Sulfanilylphenylharnstoff-Komplexe
AT334134B (de) Bekampfung von pilzschadlingen
DE2536951C3 (de) Triazapentadiene, Verfahren zu ihrer Herstellung und diese enthaltende insektizide Mittel
DE2530680A1 (de) Neue aminoderivate von pyrido(2,3-b) pyrazincarbonsaeuren und -carbonsaeureestern
DE2755022C2 (OSRAM)
DE889447C (de) Verfahren zur Herstellung diquarternaerer Salze des 4-Amino-6-(2&#39;-aminopyrimidyl-4&#39;-amino)-chinazolins
DE2311880A1 (de) Azonaphtholsulfonsaeurederivate
DE2736448A1 (de) Substituierte benzimidazole, ihre herstellung und verwendung
DE2629756C2 (OSRAM)
AT210883B (de) Verfahren zur Herstellung von neune substituierten Aminoacetophenonen und deren Salzen
AT213872B (de) Verfahren zur Herstellung neuer basischer Phenoläther und ihrer Salze
DE1795511C3 (de) 3-Amino-5-phenyl-7-chlor-2,3dihydro-1 H-1,4-benzodiazepinon-(2)
DE1668616B2 (de) Bisdithiocarbamte, verfahren zu deren herstellung und diese enthaltendes fungizides mittel
DE905371C (de) Verfahren zur Herstellung von neuen therapeutisch wirksamen quaternaeren Ammoniumsalzen
CH370766A (de) Verfahren zur Herstellung von oral wirksamen Antidiabetika
DE2116252A1 (de) Dihydrotnazine, ihre Saureadditions salze und N Acyldenvate, Verfahren zu ihrer Herstellung und Arzneimittel, die diese Verbindungen als Wirkstoffe ent halten
AT213385B (de) Verfahren zur Herstellung alkylsubstituierter Hydrazine
AT205804B (de) Schädlingsbekämpfungsmittel auf Basis von Polyhalogen-diphenyl-sulfonen, -sulfoxyden oder -sulfiden
DE2422430C3 (de) Derivate der Secalonsäure D, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Bekämpfung von Tumoren
DE2704744C2 (de) Fettsäureamide von &amp;alpha;-Methyl-m-(trifluormethyl)-phenäthylamin, Verfahren zu ihrer Herstellung und Arzneimittel
DE2628042B2 (de) 3-Amino-tricyclo [53.1.0.3A1 -undecan, dessen Säureadditionssalze und Verfahren zur Herstellung dieser Verbindungen
DE2313845C3 (de) Thiocarbaminsäurederivate und diese enthaltende Arzneimittelzubereitungen

Legal Events

Date Code Title Description
OD Request for examination
OHW Rejection